Stanford Medicine pediatric hematologist Agnieszka Czechowicz, MD, Ph.D., has devoted her research career to improving ...

Thank you, Jenny, and thank you all for joining us today. The strength of the company's stem cell science and success in ...

Commercialization ready compound supports a new method of generating highly functional human CAR-T cells for treating infectious diseases and cancer ...

NAPLES, FL / ACCESS Newswire / March 18, 2026 / Stemtech Corporation, the global leader and pioneer in stem cell nutrition, ...

Geneticist Anne Brunet explores what aging really is, how lifestyle choices might influence longevity, and the promising frontiers of aging research. Aging is a process that affects us all. But how ...

In Japanese, the word “shinobi” evokes the ninja — blending into the background, unseen. Today, that same idea is inspiring a breakthrough in regenerative medicine.

On track for third quarter 2026 top-line trial results from anticipated pivotal Phase 2b clinical trial (ELPIS II) evaluating laromestrocel as a potential adjunct treatment for HLHS, a rare pediatric ...

India, March 18 -- Stem cell therapies using induced pluripotent stem cells have received conditional approval in Japan for treating Parkinson's disease and severe heart failure, advancing ...

Longeveron Inc. (NASDAQ:LGVN) Q4 2025 Earnings Call Transcript March 17, 2026 Longeveron Inc. beats earnings expectations.

Labware for 3D cell culture, low-bind labware, and glycan analysis kits are designed to accelerate life science ...

Commercialization ready compound supports a new method of generating highly functional human CAR-T cells for treating infectious diseases and cancer In experimental models, human CAR-T cells manufactu ...

A research team led by Albert Einstein College of Medicine scientists has developed a new strategy to engineer immune cells ...